secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001567264-26-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics updates investor slide with preliminary FY2025 financial highlights
--------------------------------------------------------------------------------

- Slide dated March 4, 2026, presents unaudited financial highlights through December 31, 2025.
- Figures are preliminary and subject to completion of financial closing procedures; may differ materially from final results.
- Slide is available on the Investor Relations section of the company's website.
- No specific revenue, earnings, or balance sheet numbers are disclosed in the 8-K or its exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000011/0001567264-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000011/intensity-20260305.htm
  HTML page:      https://secwatch.observer/filing/0001567264-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer